Shingrix Shingles Vaccine Recommended for Immunocompromised Adults: CDC Reports
The previously-used vaccine, Zostavax, was contraindicated for use in immunocompromised adults and involved live virus, unlike the Shingrix shingles vaccine.
The previously-used vaccine, Zostavax, was contraindicated for use in immunocompromised adults and involved live virus, unlike the Shingrix shingles vaccine.
Researchers say the risk-benefit profile of Shingrix still favors it being used as a shingles vaccine.